Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500.

Smerage JB, Barlow WE, Hortobagyi GN, Winer EP, Leyland-Jones B, Srkalovic G, Tejwani S, Schott AF, O'Rourke MA, Lew DL, Doyle GV, Gralow JR, Livingston RB, Hayes DF.

J Clin Oncol. 2014 Nov 1;32(31):3483-9. doi: 10.1200/JCO.2014.56.2561. Epub 2014 Jun 2.

2.

Monitoring apoptosis and Bcl-2 on circulating tumor cells in patients with metastatic breast cancer.

Smerage JB, Budd GT, Doyle GV, Brown M, Paoletti C, Muniz M, Miller MC, Repollet MI, Chianese DA, Connelly MC, Terstappen LW, Hayes DF.

Mol Oncol. 2013 Jun;7(3):680-92. doi: 10.1016/j.molonc.2013.02.013. Epub 2013 Mar 14.

3.

Circulating endothelial cells, circulating tumour cells, tissue factor, endothelin-1 and overall survival in prostate cancer patients treated with docetaxel.

Strijbos MH, Gratama JW, Schmitz PI, Rao C, Onstenk W, Doyle GV, Miller MC, de Wit R, Terstappen LW, Sleijfer S.

Eur J Cancer. 2010 Jul;46(11):2027-35. doi: 10.1016/j.ejca.2010.03.030.

PMID:
20399640
4.

Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer.

Miller MC, Doyle GV, Terstappen LW.

J Oncol. 2010;2010:617421. doi: 10.1155/2010/617421. Epub 2009 Dec 9.

5.

Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer.

De Giorgi U, Valero V, Rohren E, Mego M, Doyle GV, Miller MC, Ueno NT, Handy BC, Reuben JM, Macapinlac HA, Hortobagyi GN, Cristofanilli M.

Ann Oncol. 2010 Jan;21(1):33-9. doi: 10.1093/annonc/mdp262. Epub 2009 Jul 14.

PMID:
19602564
6.

Re: Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells.

Connelly M, Wang Y, Doyle GV, Terstappen L, McCormack R.

J Natl Cancer Inst. 2009 Jun 16;101(12):895; author reply 896-7. doi: 10.1093/jnci/djp117. Epub 2009 Jun 9. No abstract available.

PMID:
19509360
7.

Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.

De Giorgi U, Valero V, Rohren E, Dawood S, Ueno NT, Miller MC, Doyle GV, Jackson S, Andreopoulou E, Handy BC, Reuben JM, Fritsche HA, Macapinlac HA, Hortobagyi GN, Cristofanilli M.

J Clin Oncol. 2009 Jul 10;27(20):3303-11. doi: 10.1200/JCO.2008.19.4423. Epub 2009 May 18.

PMID:
19451443
8.

Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer.

Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse MA, Mitchell E, Miller MC, Doyle GV, Tissing H, Terstappen LW, Meropol NJ.

Ann Oncol. 2009 Jul;20(7):1223-9. doi: 10.1093/annonc/mdn786. Epub 2009 Mar 12.

PMID:
19282466
9.

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer.

de Bono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ, Raghavan D.

Clin Cancer Res. 2008 Oct 1;14(19):6302-9. doi: 10.1158/1078-0432.CCR-08-0872. Erratum in: Clin Cancer Res. 2009 Feb 15;15(4):1506.

10.

Monitoring serial changes in circulating human breast cancer cells in murine xenograft models.

Eliane JP, Repollet M, Luker KE, Brown M, Rae JM, Dontu G, Schott AF, Wicha M, Doyle GV, Hayes DF, Luker GD.

Cancer Res. 2008 Jul 15;68(14):5529-32. doi: 10.1158/0008-5472.CAN-08-0630.

11.

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.

Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Miller MC, Doyle GV, Tissing H, Terstappen LW, Meropol NJ.

J Clin Oncol. 2008 Jul 1;26(19):3213-21. doi: 10.1200/JCO.2007.15.8923. Erratum in: J Clin Oncol. 2009 Apr 10;27(11):1923.

PMID:
18591556
12.

Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer.

Shaffer DR, Leversha MA, Danila DC, Lin O, Gonzalez-Espinoza R, Gu B, Anand A, Smith K, Maslak P, Doyle GV, Terstappen LW, Lilja H, Heller G, Fleisher M, Scher HI.

Clin Cancer Res. 2007 Apr 1;13(7):2023-9.

13.

Endothelial cells in peripheral blood of healthy subjects and patients with metastatic carcinomas.

Rowand JL, Martin G, Doyle GV, Miller MC, Pierce MS, Connelly MC, Rao C, Terstappen LW.

Cytometry A. 2007 Feb;71(2):105-13.

14.

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

Budd GT, Cristofanilli M, Ellis MJ, Stopeck A, Borden E, Miller MC, Matera J, Repollet M, Doyle GV, Terstappen LW, Hayes DF.

Clin Cancer Res. 2006 Nov 1;12(21):6403-9.

15.

Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival.

Hayes DF, Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Miller MC, Matera J, Allard WJ, Doyle GV, Terstappen LW.

Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4218-24.

16.

Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas.

Smirnov DA, Foulk BW, Doyle GV, Connelly MC, Terstappen LW, O'Hara SM.

Cancer Res. 2006 Mar 15;66(6):2918-22.

17.

Comparison of two methods for enumerating circulating tumor cells in carcinoma patients.

Balic M, Dandachi N, Hofmann G, Samonigg H, Loibner H, Obwaller A, van der Kooi A, Tibbe AG, Doyle GV, Terstappen LW, Bauernhofer T.

Cytometry B Clin Cytom. 2005 Nov;68(1):25-30.

18.

Global gene expression profiling of circulating tumor cells.

Smirnov DA, Zweitzig DR, Foulk BW, Miller MC, Doyle GV, Pienta KJ, Meropol NJ, Weiner LM, Cohen SJ, Moreno JG, Connelly MC, Terstappen LW, O'Hara SM.

Cancer Res. 2005 Jun 15;65(12):4993-7.

19.

Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors.

Rao CG, Chianese D, Doyle GV, Miller MC, Russell T, Sanders RA Jr, Terstappen LW.

Int J Oncol. 2005 Jul;27(1):49-57.

PMID:
15942643
20.

Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer.

Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC, Fritsche HA, Hortobagyi GN, Terstappen LW.

J Clin Oncol. 2005 Mar 1;23(7):1420-30. Erratum in: J Clin Oncol. 2005 Jul 20;23(21):4808.

PMID:
15735118
21.

Circulating tumor cells, disease progression, and survival in metastatic breast cancer.

Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, Hayes DF.

N Engl J Med. 2004 Aug 19;351(8):781-91.

22.

Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer.

Hayes DF, Walker TM, Singh B, Vitetta ES, Uhr JW, Gross S, Rao C, Doyle GV, Terstappen LW.

Int J Oncol. 2002 Nov;21(5):1111-7.

PMID:
12370762

Supplemental Content

Loading ...
Support Center